Charting a course for peptide therapeutic purification success
Article
Purifying peptide APIs isn’t just a step. It’s a science of manufacturing.
So, how can pharmaceutical companies overcome specific hurdles of peptide manufacturing, pairing upstream process strategies with robust downstream processing?
At Axplora, we’ve built our name, through our heritage, solving the hardest purification challenges with speed, reliability, and imaginative precision. From lab to large-scale, we turn complexity into clarity – no compromises, no shortcuts – for both patient safety and regulatory compliance, as well as product efficacy.
- 30+ years leading in industrial chromatography
- 1000s cGMP batches released
- 99.5% OTIF performance
Want to know more ?
Download this expert article by Laurence Pegon, Head of R&D at Axplora Pompey, and explore how to chart a course for peptide therapeutic success.
DARE.PARTNER.DELIVER.